Pfizer Ltd.

NSE: PFIZER · Healthcare

₹3,968.00

as of 28 Sep 2026

AI verdict · 28 Sep 2026

Bearish 68% confidence

Confirmed revenue loss (Minipress XL discontinuation) and margin compression (profit down 5.89% despite 10.4% revenue growth) outweigh…

Strongest bull point

Stock at 52-week low with RSI 23.8 and collapsed volume (30% of average) suggests capitulation; FY26 revenue grew 10.4% YoY and dividend maintained, indicating underlying business resilience.

Strongest bear point

Confirmed product discontinuation eliminates recurring revenue, net profit declined despite topline growth signaling structural margin pressure, and 14.46% underperformance vs NIFTY indicates company-specific deterioration.

Technical Forecast · next 10 trading days

Expected

₹4,473.77 +12.8%

Range

₹4,473.06 – ₹4,500.80

Technical Forecast Fundamental Debate

Free: 5 Forecasts and 5 Debates a month. Log in with your mobile number.

Every call on PFIZER, misses included

Bearish 28 Sep 2026 → now Scores 28 Oct 2026

₹3,968.00 → ₹3,968.00 0.0%

Our accuracy

Every verdict and forecast here is dated and scored when it matures — right or wrong. The first scored results publish a month after launch.

How we score →

More Healthcare